A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The division cycle of eukaryotic cells is regulated by a family of protein kinases known as the cyclin-dependent kinases (CDKs). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The complexes formed by CDK4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. CDK4 exists, in part, as a multi-protein complex with a D-type cyclin, proliferating cell nuclear antigen and a protein, p21 (refs 7-9). CDK4 associates separately with a protein of M(r) 16K, particularly in cells lacking a functional retinoblastoma protein. Here we report the isolation of a human p16 complementary DNA and demonstrate that p16 binds to CDK4 and inhibits the catalytic activity of the CDK4/cyclin D enzymes. p16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p16, on the other hand, acts through the Retinoblastoma (Rb) pathway (Serrano et al, 1993).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Serrano et al, 1993
In the citing paper
“p16INK4A is a 16 KDa protein that directly binds to CDK4/6 and blocks the formation of cyclinD-CDK4/6 complexes, thereby preventing phosphorylation of RB and promoting expression of E2F target genes (Serrano et al., 1993).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Serrano et al., 1993
In the citing paper
“This member of the INK4a family is a cyclin D-dependent kinase CDK4 and CDK6 inhibitor, which prevents the phosphorylation of the retinoblastoma protein (Rb), therefore leading to suspension of the cell cycle before the S-phase [78,79].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [78]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationSherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationFunctional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Research works printed but not linked: 2
- Motokura, T. & Arnold, A. Biochim. biophys. Acta 1155, 63–78 (1993).
- Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. Oncogene (in the press).
Cited by
Items 301–400 of 1,022
NONO couples the circadian clock to the cell cycle
Kowalska, E., Ripperger, J. A., Hoegger, D. C., Bruegger, P., Buch, T., Birchler, T., Mueller, A., Albrecht, U., Contaldo, C., & Brown, S. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213317110 · Cited by 250
The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis
Herwig, S., & Strauss, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00581.x · Cited by 250
Oncogenic capacity of the E2F1 gene.
Johnson, D. G., Cress, W. D., Jakoi, L., & Nevins, J. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12823 · Cited by 249
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
Beijersbergen, R. L., Carlée, L., Kerkhoven, R. M., & Bernards, R. (1995) · Genes & Development · doi:10.1101/gad.9.11.1340 · Cited by 248
Hirakawa, K., Mori, M., Yoshida, M., Oikawa, S., & Kawanishi, S. (2004) · Free Radical Research · doi:10.1080/1071576042000206487 · Cited by 247
“Preparation of 32P-50-end-labeled DNA Fragments DNA fragments were obtained from the human p53([17]) and p16([18]) tumor suppressor genes and the c-Ha-ras-1 protooncogene.”
BackgroundIdentification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246
14-3-3 proteins associate with cdc25 phosphatases.
Conklin, D. S., Galaktionov, K., & Beach, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7892 · Cited by 246
Self-citationLi, J.-M., Nichols, M. A., Chandrasekharan, S., Xiong, Y., & Wang, X.-F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26750 · Cited by 246
Dar, A. A., Majid, S., de Semir, D., Nosrati, M., Bezrookove, V., & Kashani-Sabet, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227611 · Cited by 244
The cdk-activating kinase (CAK): from yeast to mammals
Kaldis, P. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050290 · Cited by 242
Mysterious liaisons: the relationship between c-Myc and the cell cycle
Obaya, A. J., Mateyak, M. K., & Sedivy, J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202749 · Cited by 242
“In addition, binding of the INK proteins to Cdk4/6 is independent of cyclins (Chan et al., 1995; Guan et al., 1994; Hannon and Beach, 1994; Hirai et al., 1995; Serrano et al., 1993).”
BackgroundHsieh, C. ‐., Klump, B., Holzmann, K., Borchard, F., Gregor, M., & Porschen, R. (1998) · PubMed · Cited by 241
Id2 Specifically Alters Regulation of the Cell Cycle by Tumor Suppressor Proteins
Lasorella, A., Iavarone, A., & Israel, M. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2570 · Cited by 241
McConnell, B. B., Gregory, F. J., Stott, F. J., Hara, E., & Peters, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1981 · Cited by 238
“Since p16 binds directly to CDK4 and CDK6, and not to CDK2 (21, 52, 62), induction of p16 in EH1 cells should principally affect the kinase activity associated with cyclin D-CDK complexes.”
BackgroundPotential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect
Li, C.-Y., Suardet, L., & Little, J. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.4971 · Cited by 239
Structural basis of inhibition of CDK–cyclin complexes by INK4 inhibitors
Jeffrey, P. D., Tong, L., & Pavletich, N. P. (2000) · Genes & Development · doi:10.1101/gad.851100 · Cited by 239
“INK4 inhibitors can bind both monomeric Cdk4/6 (Serrano et al. 1993; Hall et al. 1995; Parry et al. 1995) and cyclinD-bound Cdk4/6 (Hirai et al. 1995; Adachi et al. 1997; Reynisdottir and Massague 1997) and appear to use multiple mechanisms to inhibit the CDK and halt the progression of the cell…”
BackgroundFormation of p27-CDK complexes during the human mitotic cell cycle.
Soos, T. J., Kiyokawa, H., Yan, J. S., Rubin, M. S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J. M., & Koff, A. (1996) · PubMed · Cited by 274
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
“After the decline in p21 levels with the onset of senescence, the level of p16 dramatically increases, and it is this protein that assumes the long-term role of inhibitor for the Rb kinases, CDK4 and CDK6, which is achieved by complexation between kinase and p16 (5, 43, 276, 389, 406).”
Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T. (1996) · Genes & Development · doi:10.1101/gad.10.3.245 · Cited by 234
Mechanisms of switching on p53: a role for covalent modification?
Meek, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202951 · Cited by 236
“This induction is dependent on a product of the INK4A tumour suppressor gene which encodes two unrelated proteins, p16INK4A and p19ARF (murine protein) or p14ARF (human protein) (Quelle et al., 1995; Serrano et al., 1993).”
BackgroundRegulation of CDK/cyclin complexes during the cell cycle
Arellano, M., & Moreno, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00178-1 · Cited by 236
A non-enzymatic p21 protein inhibitor of stress-activated protein kinases
Shim, J., Lee, H., Park, J., Kim, H., & Choi, E.-J. (1996) · Nature · doi:10.1038/381804a0 · Cited by 236
Phosphate-Regulated Inactivation of the Kinase PHO80-PHO85 by the CDK Inhibitor PHO81
Schneider, K. R., Smith, R. L., & O'Shea, E. K. (1994) · Science · doi:10.1126/science.7939631 · Cited by 235
Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis
Drummond, M. J., McCarthy, J. J., Sinha, M., Spratt, H. M., Volpi, E., Esser, K. A., & Rasmussen, B. B. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00148.2010 · Cited by 235
K-ras and p16 Aberrations Confer Poor Prognosis in Human Colorectal Cancer
Esteller, M., González, S., Risques, R. A., Marcuello, E., Mangues, R., Germà, J. R., Herman, J. G., Capellà, G., & Peinado, M. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.299 · Cited by 234
Poon, R. Y., Toyoshima, H., & Hunter, T. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.9.1197 · Cited by 234
“The CDK inhibitor p16 was identified as a Cdk4-associated protein in some transformed cells (Serrano et al., 1993) and found to be a specific inhibitor for Cdk4 and Cdk6 (Hannon and Beach, 1994). p16 appears to inhibit Cdk4 and Cdk6 by displacing cyclin D (Parry et al., 1995).”
BackgroundVerhelle, D., Corral, L. G., Wong, K., Mueller, J. H., Moutouh-de Parseval, L., Jensen-Pergakes, K., Schafer, P. H., Chen, R., Glezer, E., Ferguson, G. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2317 · Cited by 234
The phosphatase system in Saccharomyces cerevisiae.
Oshima, Y. (1997) · Genes & Genetic Systems · doi:10.1266/ggs.72.323 · Cited by 232
“The third to sixth repeats of the ankyrin-like motif of Pho81p have significant similarities to that of p16INK4 which inhibits the activity of the human cyclin D/ CDK4 kinase complex (Serrano et al., 1993).”
BackgroundYang, Z. Y., Simari, R. D., Perkins, N. D., San, H., Gordon, D., Nabel, G. J., & Nabel, E. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7905 · Cited by 232
Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
Galaktionov, K., Jessus, C., & Beach, D. (1995) · Genes & Development · doi:10.1101/gad.9.9.1046 · Cited by 232
Self-citationBoussiotis, V. A., Freeman, G. J., Taylor, P. A., Berezovskaya, A., Grass, I., Blazar, B. R., & Nadler, L. M. (2000) · Nature Medicine · doi:10.1038/73144 · Cited by 231
Eosewicz, S., & Wiedenmann, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)05523-7 · Cited by 229
Guardavaccaro, D., Corrente, G., Covone, F., Micheli, L., D'Agnano, I., Starace, G., Caruso, M., & Tirone, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1797-1815.2000 · Cited by 230
“12A and B) (see also references 42 and 121) and with CDK4 and CDK6 (Fig.”
ResultInfluentialTanner, F. C., Boehm, M., Akyürek, L. M., San, H., Yang, Z.-Y., Tashiro, J., Nabel, G. J., & Nabel, E. G. (2000) · Circulation · doi:10.1161/01.cir.101.17.2022 · Cited by 229
Inhibitory Effects of 1α,25-Dihydroxyvitamin D3 on the G1–S Phase-Controlling Machinery
Jensen, S. S., Madsen, M. W., Lukas, J., Binderup, L., & Bartek, J. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0673 · Cited by 229
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
Foster, S. A., Wong, D. J., Barrett, M. T., & Galloway, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1793 · Cited by 229
“The CDK2 and CDK4 levels were reduced but only at the later passages.”
BackgroundInfluentialTP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Shahbandi, A., Nguyen, H. D., & Jackson, J. G. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.007 · Cited by 226
Characterization of a calmodulin kinase II inhibitor protein in brain
Chang, B. H., Mukherji, S., & Soderling, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10890 · Cited by 227
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“[17].”
Pinyol, M., Hernandez, L., Cazorla, M., Balbı́n, M., Jares, P., Fernandez, P. L., Montserrat, E., Cardesa, A., Lopez-Otı́n, C., & Campo, E. (1997) · Blood · doi:10.1182/blood.v89.1.272 · Cited by 226
Telomere dynamics and telomerase activity in in vitro immortalised human cells
Bryan, T. M., & Reddel, R. R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00065-8 · Cited by 222
Tam, S. W., Shay, J. W., & Pagano, M. (1994) · PubMed · Cited by 241
The Petinoblastoma Tumor Suppressor Protein
(1994) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60834-9 · Cited by 219
Draetta, G. F. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90054-x · Cited by 220
Betticher, D., Heighway, J., Hasleton, P., Altermatt, H., Ryder, W., Cerny, T., & Thatcher, N. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.52 · Cited by 219
“In several lung cancer cell lines and tumour specimens, the presence of p16 protein is inversely correlated with detectable pRb and cyclin Dl proteins (Serrano et al., 1993; Shapiro et al., 1995).”
BackgroundQuelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
Tagawa, H. (2005) · Blood · doi:10.1182/blood-2005-02-0542 · Cited by 217
“Median, y (range) 62 (36-82) 65 (48-89) 57 (26-91) 60 (26-91) 67 (36-91) 63 (38-89) 64 (36-91)”
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.
He, J., Allen, J. R., Collins, V. P., Allalunis‐Turner, M. J., Godbout, R., Day, R. S., & James, C. D. (1994) · PubMed · Cited by 238
Patterns of gene promoter methylation in squamous cell cancer of the head and neck
Hasegawa, M., Nelson, H. H., Peters, E., Ringstrom, E., Posner, M., & Kelsey, K. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205528 · Cited by 216
“…no association of smoking and methylation silencing of another gene, the DAP-kinase gene, was observed in the same group of lung cancer patients (Kim et al., 2001b). p16INK4a regulates the RB pathway, leading to inhibition of cell cycle progression in the G1-S transition (Serrano et al., 1993).”
BackgroundShibata, K. R., Aoyama, T., Shima, Y., Fukiage, K., Otsuka, S., Furu, M., Kohno, Y., Ito, K., Fujibayashi, S., Neo, M., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0225 · Cited by 215
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation
Lin, A. W., & Lowe, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091100298 · Cited by 215
Gauthier, M. L., Berman, H. K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y. Y., Kerlikowske, K., & Tlsty, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.017 · Cited by 214
“Paradoxically, overexpression of p16 can represent two different biological processes; a response to cellularstress or abrogation of functional Rb signaling (Bates et al., 1994; Parry et al., 1995; Serrano et al., 1993).”
BackgroundSauer, K., Knoblich, J. A., Richardson, H., & Lehner, C. F. (1995) · Genes & Development · doi:10.1101/gad.9.11.1327 · Cited by 214
Park, M.-T., & Lee, S.-J. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.060 · Cited by 200
“The INK4A (p16) protein, which was originally identified as a CDK4-interacting protein that inhibits CDK4 kinase activity (Serrano et al., 1993), has been mapped to chromosome 9p21 (Kamb et al.”
BackgroundGalipeau, P. C., Prevo, L. J., Sanchez, C. A., Longton, G. M., & Reid, B. J. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2087 · Cited by 214
“In contrast, diploid clones with 9p LOH were rarely associated with aneuploidy or increased 4N fractions in the absence of 17p LOH and tended to spread to large regions of esophageal mucosa, possibly as a consequence of inactivation of p16’s G 1/S-phase- or senescencerelated functions ( 63 ,64).”
BackgroundBetz, B. L., Strobeck, M. W., Reisman, D. N., Knudsen, E. S., & Weissman, B. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205706 · Cited by 212
“We also observed a shift of RB to its active/hypophosphorylated form and a loss of cyclin A and Cdk2. p16ink4a is known to trigger an accumula- tion of hypophosphorylated RB by inhibiting Cdk4/6 activity (Koh et al., 1995; Lukas et al., 1995; Serrano et al., 1993).”
BackgroundFernàndez, V., Hartmann, E., Ott, G., Campo, E., & Rosenwald, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.019 · Cited by 211
Roy, P. G., & Thompson, A. M. (2006) · The Breast · doi:10.1016/j.breast.2006.02.005 · Cited by 210
Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity
Ghosh, R., Nadiminty, N., Fitzpatrick, J. E., Alworth, W. L., Slaga, T. J., & Kumar, A. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411429200 · Cited by 210
Age-related inflammation triggers skeletal stem/progenitor cell dysfunction
Josephson, A. M., Bradaschia-Correa, V., Lee, S., Leclerc, K., Patel, K. S., Muinos Lopez, E., Litwa, H. P., Neibart, S. S., Kadiyala, M., Wong, M. Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810692116 · Cited by 211
Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway.
Deshaies, R. J., Chau, V., & Kirschner, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07004.x · Cited by 211
Brotherton, D. H., Dhanaraj, V., Wick, S., Brizuela, L., Domaille, P. J., Volyanik, E., Xu, X., Parisini, E., Smith, B. O., Archer, S. J., et al. (1998) · Nature · doi:10.1038/26164 · Cited by 210
“Second, the INK4 family, which is specific for Cdk4 and Cdk6”
BackgroundSelf-citationDeGregori, J., Leone, G., Ohtani, K., Miron, A., & Nevins, J. R. (1995) · Genes & Development · doi:10.1101/gad.9.23.2873 · Cited by 210
Majid, S., Kikuno, N., Nelles, J., Noonan, E., Tanaka, Y., Kawamoto, K., Hirata, H., Li, L. C., Zhao, H., Okino, S. T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2290 · Cited by 209
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 206
“p15 and p16 impede Rb phosphorylation and S-phase entry [112].”
BackgroundN-terminal polyubiquitination and degradation of the Arf tumor suppressor
Kuo, M.-L., den Besten, W., Bertwistle, D., Roussel, M. F., & Sherr, C. J. (2004) · Genes & Development · doi:10.1101/gad.1213904 · Cited by 208
“Although most cellular proteins degraded in the proteasome are ubiquitinated, proteins such as ornithine decarboxylase (Li and Coffino 1992), tau (David et al. 2002), and the Cdk inhibitor p21Cip1 (Sheaff et al. 2000) can be directed to the proteasome without prior ubiquitination.”
BackgroundFranco, J., Witkiewicz, A. K., & Knudsen, E. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2270 · Cited by 207
“The only known functional target of p16ink4a are the kinases CDK4 and CDK6, and a plethora of data support this concept [9, 18-23].”
BackgroundVasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Wagner, M., Greten, F. R., Weber, C. K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H., Adler, G., & Schmid, R. M. (2001) · Genes & Development · doi:10.1101/gad.184701 · Cited by 207
“The entry into the cell cycle is further controlled by the Ink4 protein family that includes p16Ink4a and the closely related p15Ink4b, p18Ink4c, and p19Ink4d proteins (Serrano et al. 1993; Guan et al. 1994; Hannon and Beach 1994; Chan et al. 1995).”
BackgroundThe ageing kidney: Molecular mechanisms and clinical implications
Fang, Y., Gong, A. Y., Haller, S. T., Dworkin, L. D., Liu, Z., & Gong, R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101151 · Cited by 204
“In turn, activated p21CIP1 and p16INK4a suppress the phosphorylation of CDK complexes and retinoblastoma protein (Rb) (Serrano et al., 1993).”
Controlled Intracellular Processing of Fusion Proteins by TEV Protease
Kapust, R. B., & Waugh, D. S. (2000) · Protein Expression and Purification · doi:10.1006/prep.2000.1251 · Cited by 205
Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene · doi:10.1038/onc.2015.407 · Cited by 204
Melanoma genetics and the development of rational therapeutics
Chudnovsky, Y., Khavari, P. A., & Adams, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524808 · Cited by 204
“thereby blocks phosphorylation of pRb by these kinases, keeping pRb in its active state inhibiting cell-cycle progression (35).”
BackgroundTargeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
Piezzo, M., Cocco, S., Caputo, R., Cianniello, D., Gioia, G. D., Lauro, V. D., Fusco, G., Martinelli, C., Nuzzo, F., Pensabene, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186479 · Cited by 200
Aprelikova, O., Xiong, Y., & Liu, E. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18195 · Cited by 203
Abrogation of p27 by cDNA Antisense Suppresses Quiescence (G0 State) in Fibroblasts
Rivard, N., L'Allemain, G., Bartek, J., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18337 · Cited by 203
Appleman, L. J., Berezovskaya, A., Grass, I., & Boussiotis, V. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.144 · Cited by 203
The cell cycle and acute kidney injury
Price, P. M., Safirstein, R. L., & Megyesi, J. (2009) · Kidney International · doi:10.1038/ki.2009.224 · Cited by 203
Cutaneous Squamous Cell Carcinoma: From Biology to Therapy
Corchado-Cobos, R., García-Sancha, N., González-Sarmiento, R., Pérez-Losada, J., & Cañueto, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082956 · Cited by 201
“Loss of function of either p16INK4a or p14ARF may lead to unrestrained cell cycling and uncontrolled cell growth mediating pRB [40] and p53 [41].”
BackgroundThe GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression
Jin, S., Antinore, M. J., Lung, F.-D. T., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000284200 · Cited by 202
Kurata, S., Matsumoto, M., & Nakajima, H. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199609)62:3<314::aid-jcb2>3.0.co;2-u · Cited by 28
Popp, S., Waltering, S., Herbst, C., Moll, I., & Boukamp, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10321 · Cited by 201
Wakino, S., Kintscher, U., Kim, S., Yin, F., Hsueh, W. A., & Law, R. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910452199 · Cited by 201
Newt Myotubes Reenter the Cell Cycle by Phosphorylation of the Retinoblastoma Protein
Tanaka, E. M., Gann, A. A. F., Gates, P. B., & Brockes, J. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.155 · Cited by 199
“…of the INK4 class of cyclin-dependent kinase inhibitors (CDIs) (Sherr and Roberts, 1995), which specifically bind to and inhibit CDK4 and 6 (Serrano et al., 1993; Hannon and Beach, 1994; Sheaff and Roberts, 1995; Koh et al., 1995). p16 INK4 can only inhibit entry to S phase or colony…”
BackgroundFitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
A Molecular Genetic Model of Astrocytoma Histopathology
Louis, D. N. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb01062.x · Cited by 199
Sill, H., Goldman, J., & Cross, N. (1995) · Blood · doi:10.1182/blood.v85.8.2013.bloodjournal8582013 · Cited by 197
Denchi, E. L., Attwooll, C., Pasini, D., & Helin, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2660-2672.2005 · Cited by 195
“Importantly, increased levels of p16 and p19 trigger a pRB-dependent G1 arrest, inducing hypophosphorylation of pRB (40), which are crucial events in senescence (4, 42).”
BackgroundSandhu, C., Garbe, J., Bhattacharya, N., Daksis, J., Pan, C.-H., Yaswen, P., Koh, J., Slingerland, J. M., & Stampfer, M. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2458 · Cited by 194
“These data are consistent with the observations in vivo and in vitro that KIPs bind most effectively to cyclin-cdk complexes, while in vivo p15, p16, and p19 appear to bind exclusively to their cdk partners (18, 22, 50, 60).”
BackgroundResultMalignant melanoma: modern black plague and genetic black box
Chin, L., Merlino, G., & DePinho, R. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3467 · Cited by 194
“1995), a domain known to play a role in CDK4/6 interaction (Serrano et al. 1993; Brotherton et al. 1998; Russo et al. 1998).”
BackgroundAlgorithmic assessment of cellular senescence in experimental and clinical specimens
Kohli, J., Wang, B., Brandenburg, S. M., Basisty, N., Evangelou, K., Varela-Eirin, M., Campisi, J., Schilling, B., Gorgoulis, V., & Demaria, M. (2021) · Nature Protocols · doi:10.1038/s41596-021-00505-5 · Cited by 196
Hennessey, P. T., Westra, W. H., & Califano, J. A. (2009) · Journal of Dental Research · doi:10.1177/0022034509333371 · Cited by 193
Lee, M.-H., & Yang, H.-Y. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000826 · Cited by 192
Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia
Okuda, T., Shurtleff, S., Valentine, M., Raimondi, S., Head, D., Behm, F., Curcio- Brint, A., Liu, Q., Pui, C., & Sherr, C. (1995) · Blood · doi:10.1182/blood.v85.9.2321.bloodjournal8592321 · Cited by 192
Molecular markers of prostate cancer outcome
Quinn, D. I., Henshall, S. M., & Sutherland, R. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.035 · Cited by 191
“The product of INK4A was first identified as a 16-kDa molecule that inhibited the effect of CDK4, hence the designation p16 [62].”
BackgroundGenotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations
Goldstein, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.1006 · Cited by 192
Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce, N. C., Harris, D. L., & Mello, D. M. (2002) · PubMed · Cited by 217
Regulation of the G1 phase of the mammalian cell cycle
DONJERKOVIC, D., & SCOTT, D. W. (2000) · Cell Research · doi:10.1038/sj.cr.7290031 · Cited by 190
Matsumura, I., Ishikawa, J., Nakajima, K., Oritani, K., Tomiyama, Y., Miyagawa, J.-I., Kato, T., Miyazaki, H., Matsuzawa, Y., & Kanakura, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2933 · Cited by 190
“The other class of inhibitors, also known as INK4s (including p16, p15, p18, and p19 [4, 18, 22, 24, 54]), contains fourfold ankyrin repeats and specifically inhibits Cdk4 and Cdk6.”
BackgroundNucleotide metabolism, oncogene-induced senescence and cancer
Aird, K. M., & Zhang, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.017 · Cited by 166
Metadata
- Authors
- Serrano, M., Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1993-12
- Volume
- 366
- Issue
- 6456
- Pages
- 704-707
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066848701
- Cited by
- 3,650
- References
- 22
- Citations by year
- 2026: 36 · 2025: 46 · 2024: 52 · 2023: 66 · 2022: 67 · 2021: 78 · 2020: 64 · 2019: 63 · 2018: 56 · 2017: 70 · 2016: 69 · 2015: 75 · 2014: 52 · 2013: 98 · 2012: 88
- FWCI
- 78.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p16, CDK4, cyclin D, cyclin-dependent kinases, cell cycle regulation, G1 phase, kinase inhibition, retinoblastoma protein, p21, proliferating cell nuclear antigen, feedback regulation, cell proliferation
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cloning, Molecular, DNA, Glutathione Transferase, HeLa Cells, Humans, Molecular Sequence Data, Phosphorylation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Oncogene Proteins, Retinoblastoma Protein, Cyclins, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Cyclin-Dependent Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.